NRG1 / ERBB3 signaling in melanocyte development and melanoma: inhibition of differentiation and promotion of proliferation
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Summary: Neuregulin (NRG) signaling through the receptor tyrosine kinase, ERBB3, is required for embryonic development, and dysregulated signaling has been associated with cancer progression. Here, we show that NRG1/ERBB3 signaling inhibits melanocyte (MC) maturation and promotes undifferentiated, migratory and proliferative cellular characteristics. Embryonic analyses demonstrated that initial MC specification and distribution were not dependent on ERBB3 signaling. However NRG1/ERBB3 signaling was both necessary and sufficient to inhibit differentiation of later stages of MC development in culture. Analysis of tissue arrays of human melanoma samples suggests that ERBB3 signaling may also contribute to metastatic progression of melanoma as ERBB3 was phosphorylated in primary tumors compared with nevi or metastatic lesions. Neuregulin 1‐treated MCs demonstrated increased proliferation and invasion and altered morphology concomitant with decreased levels of differentiation genes, increased levels of proliferation genes and altered levels of melanoma progression and metastases genes. ERBB3 activation in primary melanomas suggests that NRG1/ERBB3 signaling may contribute to the progression of melanoma from benign nevi to malignancies. We propose that targeting ERBB3 activation and downstream genes identified in this study may provide novel therapeutic interventions for malignant melanoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Distinct Sets of Genetic Alterations in Melanoma
Curtin, J. A., Fridlyand, J., Kageshita, T., Patel, H. N., Busam, K. J., Kutzner, H., Cho, K.-H., Aiba, S., Bröcker, E.-B., LeBoit, P. E., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050092 · Cited by 2,747
MITF: master regulator of melanocyte development and melanoma oncogene
Levy, C., Khaled, M., & Fisher, D. E. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.07.008 · Cited by 1,169 · cited 2×
“…aspects of MC biology, a fine balance between its levels of mRNA expression and protein activity exists such that variation in levels of MITF function lead to differences in MC cell cycle, invasion, differentiation and melanogenesis (Hou and Pavan, 2008; Levy et al., 2006; Vance and Goding, 2004).”
BackgroundIn vivo Switching of Human Melanoma Cells between Proliferative and Invasive States
Hoek, K. S., Eichhoff, O. M., Schlegel, N. C., Döbbeling, U., Kobert, N., Schaerer, L., Hemmi, S., & Dummer, R. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2491 · Cited by 743
Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity.
Guy, P. M., Platko, J. V., Cantley, L. C., Cerione, R. A., & Carraway, K. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.17.8132 · Cited by 698 · cited 2×
“…is especially critical, as ERBB3 has no kinase activity due to a substitution of critical residues in the cytoplasmic domain (Carraway et al., 1994; Guy et al., 1994; Sierke et al., 1997), and can only become phosphorylated in trans- by heterodimerization with ERBB2 or ERBB4 (Kim et al., 1998).”
BackgroundBudi, E. H., Patterson, L. B., & Parichy, D. M. (2008) · Development · doi:10.1242/dev.019299 · Cited by 136 · cited 2×
“…inducing a reduction in pigmented, TYRP1+ MCs. Interestingly, a recent analysis of a zebrafish mutant homozygous for an erbb3b null allele showed normal early larva pigment development, similar to our findings in mouse Erbb3 mutants, but impaired adult pigment pattern formation (Budi et al., 2008).”
Background
Cited by
cisTopic: cis-regulatory topic modeling on single-cell ATAC-seq data
Bravo González-Blas, C., Minnoye, L., Papasokrati, D., Aibar, S., Hulselmans, G., Christiaens, V., Davie, K., Wouters, J., & Aerts, S. (2019) · Nature Methods · doi:10.1038/s41592-019-0367-1 · Cited by 456
Whiteman, D. C., Pavan, W. J., & Bastian, B. C. (2011) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2011.00880.x · Cited by 273
Self-citationRezza, A., Wang, Z., Sennett, R., Qiao, W., Wang, D., Heitman, N., Mok, K. W., Clavel, C., Yi, R., Zandstra, P., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.078 · Cited by 197
“Nrg2 signaling fromDPmay activate Erbb3 in Mc, which is involved in Mcmaturation and melanoma development (Buac et al., 2009).”
BackgroundBudi, E. H., Patterson, L. B., & Parichy, D. M. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002044 · Cited by 132
“[62,73], a further role in preventing the premature differentiation of nerve-associated precursors to hypodermal pigment cells seems likely.”
Background
Metadata
- Authors
- Buac, K., Xu, M., Cronin, J., Weeraratna, A. T., Hewitt, S. M., & Pavan, W. J.
- Venue
- Pigment Cell & Melanoma Research
- Publisher
- Wiley
- Published
- 2009-10-14
- Volume
- 22
- Issue
- 6
- Pages
- 773-784
- ISSN
- 1755-1471 (ISSN-L)
- 1755-148X
- OpenAlex
- W2077812827
- Cited by
- 81
- References
- 5
- FWCI
- 2.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: NRG1 / ERBB3 signaling in melanocyte development and melanoma: inhibition of differentiation and promotion of proliferation. https://app.cochat.ai/papers/10.1111/j.1755-148x.2009.00616.x
- The paper
- Buac, K., Xu, M., Cronin, J., Weeraratna, A. T., Hewitt, S. M., & Pavan, W. J. (2009). NRG1 / ERBB3 signaling in melanocyte development and melanoma: inhibition of differentiation and promotion of proliferation. Pigment Cell & Melanoma Research. https://doi.org/10.1111/j.1755-148x.2009.00616.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.